相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein
Ilka Wahl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2022)
Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact
Brenda Oseno et al.
PARASITES & VECTORS (2022)
Bacillus subtilis spores as delivery system for nasal Plasmodium falciparum circumsporozoite surface protein immunization in a murine model
Maria Edilene M. de Almeida et al.
SCIENTIFIC REPORTS (2022)
The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria
Lawrence T. Wang et al.
CELL REPORTS (2022)
Identification of a neutralizing epitope within minor repeat region of Plasmodium falciparum CS protein
J. Mauricio Calvo-Calle et al.
NPJ VACCINES (2021)
Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
Robert M. Mugo et al.
MALARIA JOURNAL (2021)
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
Tossapol Pholcharee et al.
NATURE COMMUNICATIONS (2021)
Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough?
Navneet Arora et al.
RISK MANAGEMENT AND HEALTHCARE POLICY (2021)
Overdiagnosis of Malaria Illness in an Endemic Setting: A Facility-Based Surveillance Study in Malawi
Ingrid Peterson et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo
Yevel Flores-Garcia et al.
PLOS PATHOGENS (2021)
Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity
Liriye Kurtovic et al.
FRONTIERS IN IMMUNOLOGY (2021)
Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice
Liriye Kurtovic et al.
FRONTIERS IN IMMUNOLOGY (2021)
Multi-functional antibody profiling for malaria vaccine development and evaluation
D. Herbert Opi et al.
EXPERT REVIEW OF VACCINES (2021)
The effect of community-driven larval source management and house improvement on malaria transmission when added to the standard malaria control strategies in Malawi: a cluster-randomized controlled trial
Robert S. McCann et al.
MALARIA JOURNAL (2021)
Functional human IgA targets a conserved site on malaria sporozoites
Joshua Tan et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it
Anja Ramstedt Jensen et al.
IMMUNOLOGICAL REVIEWS (2020)
RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform
Mark D. Langowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Role of Opsonophagocytosis in Immune Protection against Malaria
Wolfgang W. Leitner et al.
VACCINES (2020)
Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response
Hayley A. McNamara et al.
CELL HOST & MICROBE (2020)
Submicroscopic malaria infection is not associated with fever in cross-sectional studies in Malawi
Jimmy Vareta et al.
MALARIA JOURNAL (2020)
Targets of complement-fixing antibodies in protective immunity against malaria in children
Linda Reiling et al.
NATURE COMMUNICATIONS (2019)
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
Neville K. Kisalu et al.
NATURE MEDICINE (2018)
Correlating efficacy and immunogenicity in malaria vaccine trials
Matthew B. B. McCall et al.
SEMINARS IN IMMUNOLOGY (2018)
Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
Itziar Ubillos et al.
BMC MEDICINE (2018)
Production and Molecular Characterization of Plasmodium falciparum Recombinant Circumsporozoite Protein with 37 NANP and 4 NVDP Epitopes
Yunus Uyar et al.
MIKROBIYOLOJI BULTENI (2017)
malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication
David C. Kaslow et al.
PLOS MEDICINE (2017)
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains
Raul Herrera et al.
INFECTION AND IMMUNITY (2015)
Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response
Danielle I. Stanisic et al.
INFECTION AND IMMUNITY (2015)
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
Noah S. Butler et al.
NATURE IMMUNOLOGY (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya
Frances Ibison et al.
PLOS ONE (2012)
Determinants of relapse periodicity in Plasmodium vivax malaria
Nicholas J. White
MALARIA JOURNAL (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children
Amolo S. Asito et al.
MALARIA JOURNAL (2008)
An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion
D Rathore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization
BC Urban et al.
INFECTION AND IMMUNITY (2005)
C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria
ES Bergmann-Leitner et al.
INTERNATIONAL IMMUNOLOGY (2005)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei
V Meraldi et al.
VACCINE (2003)
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria
KE Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Autoimmunity and malaria: what are they doing together?
CT Daniel-Ribeiro et al.
ACTA TROPICA (2000)